Convalescent plasma and hyperimmune immunoglobulin to prevent infection with SARS-CoV-2

Sarah J. Valk; Vanessa Piechotta; Catherine Kimber; Khai Li Chai; Ina Monsef; Carolyn Doree; Erica M. Wood; Abigail A. Lamikanra; David J. Roberts; Zoe McQuilten; Cynthia So-Osman; Lise J. Estcourt; Nicole Skoetz

doi:10.1002/14651858.CD013802

Convalescent plasma and hyperimmune immunoglobulin to prevent infection with SARS-CoV-2

Sarah J. Valk, Vanessa Piechotta, Catherine Kimber, Khai Li Chai, Ina Monsef, Carolyn Doree, Erica M. Wood, Abigail A. Lamikanra, David J. Roberts, Zoe McQuilten, Cynthia So-Osman, Lise J. Estcourt^*, Nicole Skoetz

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

5 Citations (Scopus)

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess whether convalescent plasma or hyperimmune immunoglobulin transfusion is effective and safe to prevent infection with SARS-CoV-2 and development of COVID-19; and to maintain the currency of the evidence, using a living systematic review approach.

Original language	English
Article number	CD013802
Journal	The Cochrane database of systematic reviews
Volume	2020
Issue number	12
DOIs	https://doi.org/10.1002/14651858.CD013802
Publication status	Published - 6 Jan 2021
Externally published	Yes

Bibliographical note

Publisher Copyright:
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Access to Document

10.1002/14651858.CD013802

Cite this

Valk, S. J., Piechotta, V., Kimber, C., Chai, K. L., Monsef, I., Doree, C., Wood, E. M., Lamikanra, A. A., Roberts, D. J., McQuilten, Z., So-Osman, C., Estcourt, L. J., & Skoetz, N. (2021). Convalescent plasma and hyperimmune immunoglobulin to prevent infection with SARS-CoV-2. The Cochrane database of systematic reviews, 2020(12), Article CD013802. https://doi.org/10.1002/14651858.CD013802

@article{48df110d1d19480cb8f8a7e00cc2ee8c,

title = "Convalescent plasma and hyperimmune immunoglobulin to prevent infection with SARS-CoV-2",

abstract = "Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess whether convalescent plasma or hyperimmune immunoglobulin transfusion is effective and safe to prevent infection with SARS-CoV-2 and development of COVID-19; and to maintain the currency of the evidence, using a living systematic review approach.",

author = "Valk, {Sarah J.} and Vanessa Piechotta and Catherine Kimber and Chai, {Khai Li} and Ina Monsef and Carolyn Doree and Wood, {Erica M.} and Lamikanra, {Abigail A.} and Roberts, {David J.} and Zoe McQuilten and Cynthia So-Osman and Estcourt, {Lise J.} and Nicole Skoetz",

note = "Publisher Copyright: Copyright {\textcopyright} 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.",

year = "2021",

month = jan,

day = "6",

doi = "10.1002/14651858.CD013802",

language = "English",

volume = "2020",

journal = "The Cochrane database of systematic reviews",

issn = "1465-1858",

publisher = "Cochrane Collaboration",

number = "12",

}

TY - JOUR

T1 - Convalescent plasma and hyperimmune immunoglobulin to prevent infection with SARS-CoV-2

AU - Valk, Sarah J.

AU - Piechotta, Vanessa

AU - Kimber, Catherine

AU - Chai, Khai Li

AU - Monsef, Ina

AU - Doree, Carolyn

AU - Wood, Erica M.

AU - Lamikanra, Abigail A.

AU - Roberts, David J.

AU - McQuilten, Zoe

AU - So-Osman, Cynthia

AU - Estcourt, Lise J.

AU - Skoetz, Nicole

PY - 2021/1/6

Y1 - 2021/1/6

N2 - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess whether convalescent plasma or hyperimmune immunoglobulin transfusion is effective and safe to prevent infection with SARS-CoV-2 and development of COVID-19; and to maintain the currency of the evidence, using a living systematic review approach.

AB - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess whether convalescent plasma or hyperimmune immunoglobulin transfusion is effective and safe to prevent infection with SARS-CoV-2 and development of COVID-19; and to maintain the currency of the evidence, using a living systematic review approach.

UR - http://www.scopus.com/inward/record.url?scp=85103049162&partnerID=8YFLogxK

U2 - 10.1002/14651858.CD013802

DO - 10.1002/14651858.CD013802

M3 - Article

AN - SCOPUS:85103049162

SN - 1465-1858

VL - 2020

JO - The Cochrane database of systematic reviews

JF - The Cochrane database of systematic reviews

IS - 12

M1 - CD013802

ER -

Convalescent plasma and hyperimmune immunoglobulin to prevent infection with SARS-CoV-2

Abstract

Bibliographical note

Access to Document

Other files and links

Fingerprint

Cite this